A Phase I Study of Single Agent Perifosine for Recurrent Pediatric Solid Tumors
[Protocol 08-091] |
Dunkel, Ira |
|
A Phase I Study of the Hu3F8 Antibody plus GM-CSF in Patients with Relapsed/Refractory Neuroblastoma
[Protocol 12-230] |
Kushner, Brian |
|
A Phase I Study of the NY-ESO-1 Vaccine plus Ipilimumab in Patients with Inoperable or Metastatic Melanoma
[Protocol 12-253] |
Wolchok, Jedd |
|
A Phase I Study of the Treatment of Beta-Thalassemia with a Gene Transfer Approach
[Protocol 10-164] |
Boulad, Farid |
|
A Phase I Study of Tigecycline in Patients with Relapsed or Refractory Acute Myeloid Leukemia
[Protocol 12-148] |
Tallman, Martin |
- Leukemia
- Acute Myelocytic Leukemia
- Acute Myelogenous Leukemia
|
A Phase I Study of Topical Calcitriol (Compound 31543) to Prevent Hair Loss in Women Receiving Paclitaxel for Advanced Breast Cancer
[Protocol 11-205] |
Lacouture, Mario |
|
A Phase I Study of TRC105 plus Bevacizumab in Patients with Recurrent Glioma
[Protocol 12-217] |
Omuro, Antonio |
|
A Phase I Study of Veliparib Given with Radiation Therapy to the Chest Wall and Lymph Nodes in Patients with Inflammatory or Recurrent Breast Cancer
[Protocol 12-215] |
Ho, Alice |
|
A Phase I Study of Vemurafenib in Adolescents with Inoperable Stage IIIC/IV Melanoma with V600 BRAF Mutations
[Protocol 11-198] |
Pratilas, Christine |
|
A Phase I Study of VTX-2337 Plus Doxil in Patients with Recurrent or Persistent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
[Protocol 11-110] |
Bell-McGuinn, Katherine |
|
A Phase I Study of Whole Brain Radiation Therapy plus Sorafenib for Patients with Breast Cancer Brain Metastases
[Protocol 12-046] |
Seidman, Andrew |
- Brain Tumors, Metastatic
- Breast Cancer
|
A Phase I Study of WT1-Sensitized T cells for Residual or Relapsed Leukemia after Allogeneic Hematopoietic Progenitor Cell Transplantation
[Protocol 07-055] |
O'Reilly, Richard |
|
A Phase I Study of WT1-Specific Donor-Derived T Cells in Patients with Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia after T-Cell-Depleted Allogeneic Stem Cell Transplantation
[Protocol 12-175] |
Koehne, Guenther |
|
A Phase I Study of WT1-Specific T Cells for the Treatment of Patients with Advanced Ovarian, Primary Peritoneal, and Fallopian Tube Cancers
[Protocol 06-155] |
O'Cearbhaill, Roisin |
|
A Phase I Study of Xenogeneic CD20 DNA Vaccination in Patients with B-cell Lymphoma
[Protocol 07-100] |
Palomba, M. Lia |
|
A Phase I Study of Yttrium-90 Attached to Chimeric Monoclonal Antibody CG250 in Patients with Advanced Renal Cancer
[Protocol 05-031] |
Larson, Steven |
|
A Phase I Trial of a New Vaccine (Globo-H-GM2-sTn-TF-Tn) for Patients with Epithelial Ovarian, Fallopian Tube, or Peritoneal Cancer in First Remission
[Protocol 09-184] |
Sabbatini, Paul |
|
A Phase I Trial of a Trivalent Vaccine with Escalating Doses of the Immunological Adjuvant OPT-821 Plus Oral ß-Glucan for High-Risk Neuroblastoma
[Protocol 05-075] |
Kushner, Brian |
|
A Phase I Trial of B-Cell Acute Lymphoblastic Leukemia Treated with Autologous T Cells Gene-Targeted to the B-Cell Antigen CD19
[Protocol 09-114] |
Davila, Marco |
- Leukemia
- Acute Lymphoblastic Leukemia
|
A Phase I Trial of Gemcitabine and Split-Dose Cisplatin plus Everolimus in Patients with Advanced Urothelial Cancer
[Protocol 10-106] |
Bajorin, Dean |
|
